Literature DB >> 1700826

Functional comparison of transactivation by human retrovirus rev and rex genes.

H Sakai1, H Siomi, H Shida, R Shibata, T Kiyomasu, A Adachi.   

Abstract

The effect of rev-responsive element deletion on human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) gene expression was examined. The phenotypes of HIV-1 and HIV-2 provirus DNAs lacking the rev-responsive element, as determined by transfection experiments, were indistinguishable from those of virus DNAs carrying rev gene mutations. By using rev-response elements derived from these two viruses, we developed two monitoring systems to evaluate the functionality of HIV-1 rev, HIV-2 rev, and human T-lymphotropic virus type I rex. In both systems, HIV-1 rev and human T-lymphotropic virus type I rex transactivated HIV-2 very efficiently. On the contrary, HIV-2 rev and human T-lymphotropic virus type I rex were poor activators of HIV-1. No functional replacement of rex by HIV-2 rev was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700826      PMCID: PMC248742     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

3.  Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes.

Authors:  A B Rabson; D F Daugherty; S Venkatesan; K E Boulukos; S I Benn; T M Folks; P Feorino; M A Martin
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

4.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.

Authors:  C A Rosen; E Terwilliger; A Dayton; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  HIV/HTLV gene nomenclature.

Authors:  R Gallo; F Wong-Staal; L Montagnier; W A Haseltine; M Yoshida
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

9.  Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing.

Authors:  H Siomi; H Shida; S H Nam; T Nosaka; M Maki; M Hatanaka
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

10.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.

Authors:  M H Malim; J Hauber; R Fenrick; B R Cullen
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

View more
  18 in total

1.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Genetic characterization of simian immunodeficiency virus isolated from an African mandrill.

Authors:  H Sakai; J Sakuragi; S Sakuragi; R Shibata; M Hayami; A Ishimoto; A Adachi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Identification of feline immunodeficiency virus rev gene activity.

Authors:  T Kiyomasu; T Miyazawa; T Furuya; R Shibata; H Sakai; J Sakuragi; M Fukasawa; N Maki; A Hasegawa; T Mikami
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif.

Authors:  T J Hope; B L Bond; D McDonald; N P Klein; T G Parslow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Integration is essential for efficient gene expression of human immunodeficiency virus type 1.

Authors:  H Sakai; M Kawamura; J Sakuragi; S Sakuragi; R Shibata; A Ishimoto; N Ono; S Ueda; A Adachi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.

Authors:  T Miura; R Shibata; A Adachi; T Kuwata; J Chen; M Jin; E Ido; M Hayami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.

Authors:  J Katahira; T Ishizaki; H Sakai; A Adachi; K Yamamoto; H Shida
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts.

Authors:  R Grassmann; S Berchtold; C Aepinus; C Ballaun; E Boehnlein; B Fleckenstein
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

10.  Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

Authors:  H Sakai; R Shibata; J Sakuragi; S Sakuragi; M Kawamura; A Adachi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.